Abstract
Successful immunotherapy ultimately depends on the ability of immune effector cells to infiltrate tumor tissues. A major site of extravasation of immune effector cells out of the blood and into tissues occurs across specialized post-capillary high endothelial venules (HEV).1 Lymphocyte emigration into tissues involves a complex multistep adhesion cascade.2,3 The L-selectin leukocyte adhesion molecule is responsible for mediating the initial attachment and slow rolling of lymphocytes along the luminal surface of HEV under hemodynamic shear conditions, a crucial first step in the extravasation of immune effector cells into lymph nodes and Peyer’s patches as well as at extralymphoid sites. Firm adhesion of lymphocytes to HEV and transendothelial migration are dependent on the interaction of the leukocyte integrin, leukocyte function associated antigen-1 (LFA-1), with intercellular adhesion molecule-1 (ICAM-1) and ICAM-2 on endothelial cells. The α4β1 and α4β7 integrins have also been implicated in recruitment of lymphocytes to tissues through binding to their cognate receptors on endothelium including vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Blockade of these leukocyte-endothelial cell adhesive interactions severely compromises anti-tumor immunity.4–7 The immune effector cells that are recruited to tissues via L-selectin-, LFA-1-, α4β1- and/or α4β7-dependent mechanisms include: naive and memory CD4 and CD8 T cells, monocytes, neutrophils, and CD56bright/CD56dim natural killer (NK) cell subsets.2,3,8
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Girard, J. P., and T. A. Springer. 1995. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today 16: 449–457.
Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272: 60–66.
Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57: 827–872.
Schweighoffer, T., W. Schmidt, M. Buschle, and M. L. Birnstiel. 1996. Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines. Gene Therapy 3: 819–824.
Kagamu, H., J. E. Touhalisky, G. E. Plautz, J. C. Krauss, and S. Shu. 1996. Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes. Cancer Res. 56: 4338–4342.
Rosato, A., A. Zambon, B. Macino, S. Mandruzzato, V. Bronte, G. Milan, P. Zanovello, and D. Collavo. 1996. Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. Int. J. Cancer 65: 847–851.
Rosato, A., V. Bronte, S. Mandruzzato, A. Zambon, F. Calderazzo, G. Biasi, P. Zanovello, and D. Collavo. 1992. Role of adhesion molecules in the immune reaction to M-MSV induced tumors. Int. J. Cancer Suppl. 7: 24–27.
Frey, M., N. Packianathan, T. A. Fehniger, M. E. Ross, W. C. Wang, C. C. Stewart, M. A. Caligiuri, and S. S. Evans. 1998. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 161: 400–408.
Piali, L., A. Fichtel, H. J. Terpe, B. A. Imhof, and R. H. Gisler. 1995. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. Exp. Med. 181: 811–816.
Wu, N. Z., B. Klitzman, R. Dodge, and M. W. Dewhirst. 1992. Diminished leukocyte-endothelial interaction in tumor microvessels. Cancer Res. 52: 4265–4268.
Melder, R. J., G. C. Koenig, B. P. Witwer, N. Safabakhsh, L. L. Munn, and R. K. Jain. 1996. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2: 992–997.
Onrust, S. V., P. M. Hartl, S. D. Rosen, and D. Hanahan. 1996. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. J. Clin. Invest. 97: 54–64.
Chin, Y. H., M. W. Ye, J. P. Cai, and X. M. Xu. 1996. Differential regulation of tissue-specific lymph node high endothelial venule cell adhesion molecules by tumor necrosis factor and transforming growth factor-β1 Immunology 87: 559–565.
Bereta, J., M. Bereta, S. Cohen, and M. C. Cohen. 1993. Regulation of VCAM-1 expression and involvement in cell adhesion to murine microvascular endothelium. Cell. Immunol. 147: 313–330.
Ferrara, N. 1996. Natural killer cells, adhesion and tumor angiogenesis. Nature Med. 2: 971–972.
Jain, R. K., G. C. Koenig, M. Dellian, J. D. Fukumura, L. L. Mun, and R. J. Melder. 1996. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer & Metastasis Rev. 15: 195–204.
Sasaki, A., R. J. Melder, T. L. Whiteside, R. B. Herberman, and R. K. Jain. 1991. Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J. Nat. Ca. Inst. 83: 433–437.
Fukumura, D., H. A. Salehi, B. Witwer, R. F. Tuma, R. J. Melder, and R. K. Jain. 1995. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effects of tumor type, transplantation site, and host strain. Cancer Res. 55: 4824–4829.
Ohkubo, C., D. Bigos, and R. K. Jain. 1991. Interleukin-2-induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: Implications for vascularleak syndrome. Cancer Res. 51: 1561–1563.
Gamble, J. R., and M. A. Vadas. 1988. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science 242: 97–99.
Yang, G., M. T. Mizuno, K. E. Hellstrom, and L. Chen. 1997. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes. J. Immunol. 158: 851–858.
Evans, S. S., R. P. Collea, M. M. Appenheimer, and S. O. Gollnick. 1993. Interferon-α induces the expression of the L-selectin homing receptor in human B lymphoid cells. J. Cell Biol. 123: 1889–1998.
Frey, M., M. M. Appenheimer, and S. S. Evans. 1997. Tyrosine kinase-dependent regulation of L-selectin expression through the Leu-13 signal transduction molecule. J. Immunol. 158: 5424–5434.
Appenheimer, M. M., P. H. Silva, R. A. Bruce, S. O. Gollnick, P. D. Aplan, and S. S. Evans. Identification of the 5′ transcriptional regulatory region of the interferon-a-inducible human L-selectin gene. (Manuscript submitted).
Jewell, A.P., and K. L. Yong. 1997. Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukemia. Acta Hematologica 97: 67–72.
Evans, S. S., M. M. Appenheimer, and S. O. Gollnick. 1994. Interferon-α induces L-selectin expression by human B lymphoid cells. J. Cell. Biochem. 18D: 270.
Evans, S. S., R. Collea, J. A. Leasure, and D. B. Lee. 1993. IFN-α induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J. Immunol. 150: 736–747.
Scarozza, A. M., J. T. Collins, and S. S. Evans. 1992. DNA synthesis in nuclei isolated from Daudi B cells: A model to study the antiproliferative mechanisms of interferon-α. J. Interferon Res. 12: 35–42.
Tovey, M.G., M. Streuli, I. Gresser, J. Gugenheim, B. Blanchard, J. Guymarho, F. Vignaux, and M. Gigou. 1987. Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc. Natl. Acad. Sci. 84: 5038–5042.
Proietti, E., C. Vanden Broecke, P. Di Marzio, S. Gessani, I. Gresser, and M. G. Tovey. 1992. Specific interferon genes are expressed in individual cells in the peritoneum and bone 1992. Specific interferon genes are expressed in individual cells in the peritoneum and bone marrow of normal mice. J. Interferon Res.. 12: 27–34.
Gresser, I., D. Guy-Grand, C. Maury, and M. T. Maunoury. 1981. Interferon induces peripheral lymphadenopathy in mice. J. Immunol. 127: 1569–1575.
Hein, W.R. and A. Supersaxo. 1988. Effect of interferon-alpha-2a on the output of recirculating lymphocytes from single lymph nodes. Immunology 64: 469–474.
Darnell, J.E., Jr. 1997. STATs and gene regulation. Science 277: 1630–1635.
Leaman, D.W., S. Leung, X. Li, and G.R. Stark. 1996. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 10: 1578–1588.
Appenheimer, M. M., P. H. Silva, R. A. Bruce, S. O. Gollnick, P. D. Aplan, and S. S. Evans. Identification of interferon responsive elements within the L-selectin gene regulatory region. Presented at the joint AAAAI/AAI/CIS meeting, Feb. 21–26, 1997, San Francisco, CA.
Walcheck, B., J. Kahn, J. M. Fisher, B. B. Wang, R. S. Fisk, D. G. Payan, C. Feehan, R. Betageri, K. Darlak, A. F. Spatola, and T. K. Kishimoto. 1996. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380: 720–723.
Steen, P. D., J. R. McGregor, C. M. Lehman, and W. E. Samlowski. 1989. Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure. J. Immunol. 143: 4324–4330.
McRae, B. L., L. J. Picker, and G. A. van Seventer. 1997. Human recombinant interferon-β influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors. Eur. J. Immunol. 27: 2650–2656.
Evans, S. S., D. B. Lee, T. Han, T. B. Tomasi, and R. L. Evans. 1990. Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 76: 2583–2593.
Deblandre, G. A., O. P. Marinx, S. S. Evans, S. Majjaj, O. Leo, D. Caput, G. A. Huez, and M. G. Wathelet. 1995. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J. Biol. Chem. 270: 23860–23866.
Tedder, TF, L. J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15: 437–442.
Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13: 127–149.
Levy, S., S. C. Todd, and H. T. Maecker. 1998. CD81 (TAPA-1), a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol 16: 89–109.
Chen, Y. X., K. Weite, D. H. Gebhard, and R. L. Evans. 1984. Induction of T cell aggregation by antibody to a 16kd human leukocyte surface antigen. J. Immunol. 133: 2496–2501.
Reid, L. E., A. H. Brasnett, C. S. Gilbert, A. C. Porter, D. R. Gewert, G. R. Stark, and I. M. Kerr. 1989. A single DNA response element can confer inducibility by both α-and γ-interferons. Proc. Natl. Acad. Sci. USA 86: 840–844.
Preece, G., G. Murphy, and A. Ager. 1996. Metalloproteinase-mediated regulation of L-selectin levels on leukocytes. J. Biol. Chem. 271: 11634–11640.
Bennett, T. A., E. B. Lynam, L. A. Sklar, and S. Rogelj. 1996. Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. J. Immunol. 156: 3093–3097.
Shecterle, L. M, and J. A. St. Cyr. 1995. Whole body hyperthermia as a potential therapeutic option. Cancer Biotherapy 10: 253–256.
Kapp, D. S. 1996. Thermal dose response, systemic hyperthermia, and metastases: old friends revisited. Int. J. Rad. Oncol. Biol. Phys. 35: 189–194.
Alpard, S. K., R. A. Vertees, W. Tao, D. J. Deyo, R. L. Brunston, Jr., and J. B. Zwischenberger. 1996. Therapeutic hyperthermia. Perfusion 11: 425–435.
Fajardo, L. F., and S. D. Prionas. 1994. Endothelial cells and hyperthermia. Int. J. Hyperthermia 10: 347–353.
R., S. Dziedzic, Y. Xu, M. A. Caligiuri, J. R. Subjeck, E. A. Repasky. Tumor cell apoptosis, lymphocyte recruitmenttumor vascular changes are induced by low temperature, long duration whole body hyperthermia. J. Cell. Physiol., in press.
Roberts, N. J., Jr. 1991. Impact of temperature elevation on immunologic defenses. Reviews Infect. Dis. 13: 462–472.
Smith, J. B., R. P. Knowlton, and S. S. Agarwal. 1978. Human lymphocyte responses are enhanced by culture at 40°C. J. Immunol. 121: 691–694.
Roberts, N. J., Jr., and R. T. Steigbigel. 1977. Hyperthermia and human leukocyte functions: Effects on response of lymphocytes to mitogen and antigen and bactericidal capacity of monocytes and neutrophils. Infect. Immunity 18: 673–679.
Heron, I., and K. Berg. 1978. The actions of interferon are potentiated at elevated temperature. Nature 274: 508–510.
Wang, W.C., L. M. Goldman, D. M. Schleider, M. M. Appenheimer, J. R. Subjeck, E. A. Repasky, and S. S. Evans. 1998. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J. Immunol. 160: 961–969.
Pavalko, F. M., and C. A. Otey. 1994. Role of adhesion molecule cytoplasmic domains in mediating interactions with the cytoskeleton. Proc. Soc. Exp. Biol. Med. 205: 282–293.
Pavalko, F. M., D. M. Walker, L. Graham, M. Goheen, C. M. Doerschuk, and G. S. Kansas. 1995. The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via α-actinin: receptor positioning in microvilli does not require interaction with α-actinin. J. Cell Biol. 129: 1155–1164.
Evans, S. S., D. M. Schleider, L. Bowman, G. S. Kansas, and J. D. Black. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. (Manuscript submitted).
D’Oleire, F., C. L. Schmitt, H. I. Robins, J. D. Cohen, and D. Spriggs. 1993. Cytokine induction in humans by 41.8°C whole-body hyperthermia. J. Natl. Can. Inst. 85: 833–834.
Robins, H. I., M. Kutz, G. J. Wiedemann, D. M. Katschinski, D. Paul, E. Grosen, C. L. Tiggelaar, D. Spriggs, W. Gillis, and F. d’Oleire. 1995. Cytokine induction by 41.8°C whole body hyperthermia. Cancer Letters 97: 195–201.
Roberts, N. J., Jr. 1986. Differential effects of hyperthermia on human leukocyte production of interferon-α and interferon-γ. Proc. Soc. Exper. Biol. Med. 183: 42–47.
Downing, J. F., M. W. Taylor, K. M. Wei, and R. S. Elizondo. 1987. In vivo hyperthermia enhances plasma antiviral activity and stimulates peripheral lymphocytes for increased synthesis of interferon-γ. J. Interferon Res. 7: 185–193.
Evans, S. S., W. C. Wang, R. Burd, D. M. Schleider, J. R. Subjeck, and E. A. Repasky. Whole body hyperthermia augments L-selectin-dependent adhesion of lymphocytes to lymph node high endothelial venules. (Manuscript in preparation).
Evans, S. S., W. C. Wang, L. M. Goldman, J. Subjeck, and E. A. Repasky. Hyperthermia-induced enhancement of lymphocyte adhesion to vascular endothelium. Presented at the Radiation Research Society Meeting, April 1996.
Sakakibara, T., H. L. Bumpers, F. Chen, R. B. Bankert, M. A. Arredondo, S. B. Edge, and E. A. Repasky. 1996. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J. Sci. Am. 2: 291–300.
Matsuda, H., F. R. Strebel, T. Kaneko, L. L. Danhauser, G. N. Jenkins, N. Toyota, J. M. Bull. 1997. Long duration-mild whole body hyperthermia of up to 12 hours in rats: feasibility, and efficacy on primary tumor and auxiliary lymph node metastases of a mammary adenocarcinoma: implications for adjuvant therapy. Int. J. Hyperthermia. 13: 89–98.
Hachiya, H., K. Okada, A. Sakurai, N. Satomi, and K. Haranaka. 1992. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia against heterotransplanted human prostatic carcinoma and its lymph node metastasis in nude mice. Mol. Biother. 4: 34–39.
Sakaguchi, Y., M. Makino, T. Kaneko, L. C. Stephens, F. R. Strebel, L. L. Danhauser, G. N. Jenkins, and J. M. Bull. 1994. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res. 54: 2223–2227.
Geppert, T. D., and P. E. Lipsky. 1991. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J. Immunol. 146: 3298–3305.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Evans, S.S. et al. (1998). Regulation of Leukocyte-Endothelial Cell Interactions in Tumor Immunity. In: Mihich, E., Croce, C. (eds) The Biology of Tumors. Pezcoller Foundation Symposia, vol 9. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1352-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1352-4_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1354-8
Online ISBN: 978-1-4899-1352-4
eBook Packages: Springer Book Archive